Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 28, 2014 12:00 ET | Source: Genelux

Genelux Appoints George Vandeman and Thomas Zindrick to Board of Directors

SAN DIEGO, CA--(Marketwired - May 28, 2014) - Genelux Corporation, a clinical-stage biopharmaceutical company that develops vaccinia virus-based cancer therapeutics and diagnostics, today announced...
May 15, 2014 13:17 ET | Source: Genelux

Update: Genelux Corporation Announces Former Amgen and Abbott Executives to Succeed Founder Aladar A. Szalay, Ph.D., as CEO, Chairman of the Board

SAN DIEGO, CA--(Marketwired - May 15, 2014) - Genelux Corporation, a clinical-stage biopharmaceutical company that develops vaccinia virus-based cancer therapeutics and diagnostics, today...
May 12, 2014 10:58 ET | Source: Genelux

Genelux Corporation Announces Former Amgen and Abbott Executives to Succeed Founder Aladar A. Szalay, Ph.D., as CEO, Chairman of the Board

SAN DIEGO, CA--(Marketwired - May 12, 2014) - Genelux Corporation, a clinical-stage biopharmaceutical company that develops vaccinia virus-based cancer therapeutics and diagnostics, today announced...
April 08, 2014 11:17 ET | Source: Genelux

Genelux Corporation CEO, Dr. Aladar A. Szalay, to Give a Keynote Lecture at the 8th International Conference on Oncolytic Virus Therapeutics

SAN DIEGO, CA--(Marketwired - Apr 8, 2014) - Genelux Corporation, a clinical-stage biopharmaceutical company developing vaccinia virus-based cancer therapies and diagnostics, today announced that...
February 11, 2014 08:00 ET | Source: Genelux

Genelux Corporation Appoints John D. Prunty Chief Financial Officer

SAN DIEGO, CA--(Marketwired - Feb 11, 2014) - Genelux Corporation, a clinical-stage biopharmaceutical company that develops vaccinia virus-based cancer therapeutics and diagnostics, announced today...